Senior insider sale
Chief Medical Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.85M
62.51K shares
FOFF ERIN PENNOCK plans to sell 62.51K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/26/2025 | Restricted Stock Unit Grant N/A | 12.07K | — |
7/18/2025 | Restricted Stock Unit Grant N/A | 12.93K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 6.35K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.55K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 3.35K | — |
| Total | 36.24K | ||
Completed
Units to sell
3.66K
Market value
$138.6K
Units to sell
15.05K
Market value
$553.5K
Units to sell
15K
Market value
$549.3K
Units to sell
13.46K
Market value
$493.6K
Planned — Approximate Date
Units to sell
15.36K
Market value
$119.9K
Units
62.51K
Value
$1.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 3.66K | $138.6K | — | Completed |
7/16/2026 | 15.05K | $553.5K | — | Completed |
7/15/2026 | 15K | $549.3K | — | Completed |
7/15/2026 | 13.46K | $493.6K | — | Completed |
| Planned — Approximate Date | ||||
10/15/2026 | 15.36K | $119.9K | NASDAQ | Planned |
| Total | 62.51K | $1.85M | ||